Cash & equivalents decreased 28.5%
Cash & equivalents changed -28.5% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -28.5% from the comparable as-filed period.
Operating income changed -17.4% from the comparable as-filed period.
Current liabilities changed -27.9% from the comparable as-filed period.
Noncurrent long-term debt changed +77.6% from the comparable as-filed period.
Total assets changed -27.3% from the comparable as-filed period.
Current assets changed -26.7% from the comparable as-filed period.
Working capital changed -26.4% from the comparable as-filed period.
Free-cash-flow proxy changed +0.1% from the comparable as-filed period.
Operating cash flow changed +0.1% from the comparable as-filed period.
Working capital / assets changed +93 basis points from the comparable as-filed period.
Stock-based compensation changed +12.1% from the comparable as-filed period.
Research & development changed +7.3% from the comparable as-filed period.
Current ratio changed +1.7% from the comparable as-filed period.
Capital expenditure changed from 0 to 0 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.